702 presents... The Moth

Gethwana Mahlase told her story to give hope to others - you should listen

Social activist Gethwana Mahlase is a nurse and NGO founder and told her story at the recent "702 presents The Moth" showcase event - to rapturous applause.

On 1 December South Africans will commemorate World Aids Day and Gethwana says much more needs to be done.

She gave up her day job as a nurse and, through hard work and determination started her NGO in 1995.

She lost friends and relatives to HIV/AIDS and started working in her community to address mens' role and women's rights in fighting the disease.

Mahlase spent many years as a community HIV/AIDS educator in rural Kwa-Zulu Natal and is now writing a book on stories she collected from grandmothers who lost all or almost all their children to the illness.

We have not yet won the fight. We are not yet where we want to be.

Gethwana Mahlase, social activist

She believes that NGOs have an important role to play in advocating for HIV/AIDS and providing support to communities.

According to Mahlase, the stigma of HIV/AIDS still exists but has become internalised HIV positive people.

It's not so much that people from the outside that stigmatise. It's the people themselves who are afraid and carry internal fears.

Gethwana Mahlase, social activist

She says the perception of risk has been reduced over the years due to the development of ARV treatment and other drugs.

Gethwana was one of the storytellers featured in our podcast series "702 presents The Moth". Her story received a massive response when she told it at the Market Theatre.

702 partnered with The Moth to present unique story podcasts around issues of personal identity and experiences with HIV/ AIDS.

Click here for access to the entire archive of HIV/ AIDS related podcasts from "702 presents... The Moth".

Learn more about The Moth - an acclaimed non-for-profit organisation dedicated to the art and craft of storytelling.


This article first appeared on CapeTalk : Gethwana Mahlase told her story to give hope to others - you should listen


Recommended

by NEWSROOM AI
Read More
South Africa launches world's largest HIV vaccine study in seven years

South Africa launches world's largest HIV vaccine study in seven years

South Africa has launched the largest and most advanced HIV vaccine clinical trial to help prevent HIV infections.

Medical experts optimistic about new HIV vaccine

Medical experts optimistic about new HIV vaccine

The largest and most advanced HIV vaccine clinical trial is set to take place in South Africa.

SA historic clinical trial for HIV vaccine gives hope

SA historic clinical trial for HIV vaccine gives hope

The nationwide trial holds promise for a breakthrough in HIV that continues to affect millions of South Africans.

TAC says govt may be ill-equipped to roll out ARVs for all

TAC says govt may be ill-equipped to roll out ARVs for all

ARVs will soon be accessible all HIV+ patients, irrespective of their CD4 count. But the Treatment Action Campaign has its doubts.

Gail Johnson: Response to HIV treatment would make Nkosi Johnson proud

Gail Johnson: Response to HIV treatment would make Nkosi Johnson proud

Gail Johnson says Nkosi Johnson's activism in the fight against HIV/Aids has been validated by a visit from Cyril Ramaphosa.

ARVs soon to be available to all HIV patients, irrespective of CD4 count

ARVs soon to be available to all HIV patients, irrespective of CD4 count

By September, anyone with HIV will be able to get antiretroviral treatment irrespective of their CD4 count.

New calls for medical aid schemes to pay for HIV prevention drugs

New calls for medical aid schemes to pay for HIV prevention drugs

Medical aid companies stand to benefit from preventative HIV care packages for clients, says healthcare funder Dr Humphrey Zokufa.

Drugs will reduce risk of getting HIV - Health department on board

Drugs will reduce risk of getting HIV - Health department on board

The use of ARV's as a pre-exposure drug has proved highly effective in reducing the risk of people contracting HIV.

Popular articles
Dis-Chem drives ad expert to 'Steve Hofmeyr-like assaults' on his decoder

Dis-Chem drives ad expert to 'Steve Hofmeyr-like assaults' on his decoder

"It’s been said you can’t bore people into buying your brand. Someone should’ve pointed this out to Dis-Chem," says Andy Rice.

Bone-dry Makhanda (Grahamstown) is falling apart

Bone-dry Makhanda (Grahamstown) is falling apart

What is going on in bone-dry Makhanda (Grahamstown)? Bruce Whitfield interviews Jacko Maree (St Andrew's College).

Brilliant graduate gets 50% scholarship to study in France. Can you help?

Brilliant graduate gets 50% scholarship to study in France. Can you help?

Paris-Sorbonne University accepted Khumo Mampuru into its master’s in quantitative economics course, but he’s €12 000 short.

'BEE has closed many avenues for skilled people'

'BEE has closed many avenues for skilled people'

Africa Melane speaks to EOSA's Johannes Wessels about why so many highly skilled South Africans are taking their talents overseas.

Zuma's legal strategy is poor, says Eusebius

Zuma's legal strategy is poor, says Eusebius

Eusebius McKaiser and callers discuss the former president's stay of prosecution application.

'Public Protector is protector of something, but not protector of the public'

'Public Protector is protector of something, but not protector of the public'

Scorpio investigative journalist Pauli van Wyk and independent legal consultant Phephelaphi Dube analyse the events.

Standard Bank takes on Capitec Bank with low-fee account, gigabytes of free data

Standard Bank takes on Capitec Bank with low-fee account, gigabytes of free data

The account costs R4.95 per month; you get 1GB of free data. Swipe 4 times a month; you get 0.5GB of free data and R50 airtime.

'You can easily get a 15% total return from a share like MultiChoice'

'You can easily get a 15% total return from a share like MultiChoice'

Is there an investment case for MultiChoice? Arabile Gumede interviews Jacques Plaut, a Portfolio Manager at Allan Gray.